Below is some historical data on the post-earnings performance of Pfizer stock compared to the stock performance of peers that reported their earnings just before Pfizer. For a fair comparison ...

Filter, analyze, and streamline your search for investment opportunities using Tipranks' Stock Screener. Pfizer (PFE) has been the focus of several analyst reports recently, with mixed ratings ...

Estimates for Pfizer’s 2025 earnings have risen from $2.97 to $2.98 per share over the past 30 days. (Find the latest earnings estimates and surprises on Zacks Earnings Calendar.) The healthcare ...

Pfizer (PFE) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might want to consider some of the key factors that could influence the stock's performance in the near ...

Pfizer finds itself in the spotlight as Cantor Fitzgerald initiates analyst coverage, assigning a neutral rating to the biopharmaceutical giant. This cautious stance comes paired with a conservative ...

saw its stock rise by 3.75% in pre-market trading, reflecting investor optimism about its earnings performance and strategic initiatives. Want deeper insights? InvestingPro analysis reveals 10+ ...

Where to invest $1,000 right now? Our analyst team just revealed what they believe are the 10 best stocks to buy right now. Learn More » Yet Pfizer watchers are well aware that the large and well ...